Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
Ghislanzoni
M
M
Cusini
M
M
Zerboni
R
R
Alessi
E
E
D000212:Acyclovir / Q000627:therapeutic use; D000287:Administration, Topical; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D017245:Foscarnet / Q000008:administration & dosage*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006558:Herpes Genitalis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000008:administration & dosage*
D000998:Antiviral Agents; D063065:Organophosphonates; D017245:Foscarnet; D003596:Cytosine; D000077404:Cidofovir; D000212:Acyclovir